SurModics, Inc.
News and overview for SurModics, Inc.
SurModics Reports Fourth Quarter and Fiscal Year 2009 Results [Press Release]
Business Wire | 20 days 12 hours 28 minutes ago
SurModics, Inc. (Nasdaq: SRDX), a leading provider of drug delivery and surface modification technologies to the healthcare industry, today reported financial results for the fourth quarter and fiscal year ended September 30, 2009.
NuPathe and SurModics sign a drug delivery technology license agreement
News-Medical.Net | 22 days 2 hours 14 minutes ago
SurModics, Inc. (Nasdaq: SRDX), a leading provider of drug delivery and surface modification technologies to the healthcare industry, and NuPathe Inc
SurModics and NuPathe Partner to Develop Novel Long-Acting Parkinson's Treatment [Press Release]
Business Wire | 22 days 11 hours 58 minutes ago
SurModics, Inc. (Nasdaq: SRDX), a leading provider of drug delivery and surface modification technologies to the healthcare industry, and NuPathe Inc., a neuroscience-focused specialty pharmaceutical company, announced today that the companies have entered into a license agreement for drug delivery technology. The companies have been collaborating since 2007 on the development of a biodegradable sustained release formulation of an approved dopamine agonist. The result is NuPathe’s NP201, the ...
SurModics to Webcast Fourth Quarter and Fiscal Year 2009 Earnings Conference Call November 4 [Press Release]
Business Wire | 27 days 13 hours 29 minutes ago
SurModics, Inc. (Nasdaq: SRDX), a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it will host a live webcast of its fourth quarter and fiscal year 2009 conference call on Wednesday, November 4, at 4:00 p.m. CT. The Company will issue an earnings news release after the market closes that afternoon.
Reportlinker Adds Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems Report [Press Release]
PRNewswire | 61 days 19 hours 26 minutes ago
NEW YORK, Sept. 24 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
Midwest Insider Trading
Star Tribune (Minneapolis-St. Paul, Minn.) | 2 days 7 hours 12 minutes ago
3M Co. Robert MacDonald III officer Exercised options: 5,642 Price: $61.85 - $61.90 Date: Nov.
The Week Ahead
Star Tribune (Minneapolis-St. Paul, Minn.) | 23 days 11 hours 17 minutes ago
MONDAY Local earnings: ATS Medical Inc., Hutchinson Technology Inc., Uroplasty Inc.
Earnings
Star Tribune (Minneapolis-St. Paul, Minn.) | 20 days 8 hours 18 minutes ago
AMERICAN MEDICAL SYSTEMS HOLDINGS INC. (AMMD) Makes medical devices for physicians treating urological and gynecological disorders.
Company news
Star Tribune (Minneapolis-St. Paul, Minn.) | 22 days 6 hours 18 minutes ago
MERGERS AND ACQUISITIONS Digital Angel Corp., South St.
9 Results
Sign up for AdvaMed SmartBrief
Company Overview
| Company: | SurModics, Inc. |
|---|---|
| Industry: | Medical Devices |
| Website: | http://www.surmodics.com |
SurModics doesn't want to scratch the surface of the medical device market -- it just wants to coat it with its own special agent. The company makes special coatings for medical devices that make them easier to use, less traumatic to the body, and even useful in delivering drugs to patients. Its PhotoLink surface modification technology makes catheters and other devices slippery and easier to maneuver; PhotoLink-treated products also can be coated with drugs such as heparin, in order to reduce the incidence of blood clots. The company's Bravo polymer coating is used on Cordis' drug-coated coronary stent (among other products) and delivers drugs that prevent re-narrowing of the artery.
Key Numbers
| Sales in U.S. Dollars (mil.) | 97.1 (2008) |
|---|---|
| One-year % Growth in Sales | 32.6 (2008) |
| Net Income in U.S. Dollars (mil.) | 14.7 (2008) |
| One-year % Growth in Net Income | 340.4 (2008) |
| Number of Employees | 254 (2008) |
| One-year % Growth in Number of Employees | 4.1 (2008) |
| Fiscal Year-End | September |